1.Recombinant human growth hormone (rhGH) for the treatment of postoperative respiratory failure in surgical patients
Kaijiang YU ; Mingyan ZHAO ; Shukui DAI
Chinese Journal of General Surgery 2001;0(10):-
ObjectiveTo study the effect of recombinant human growth hormone (rhGH) on postoperative patients on mechanical ventilation.Methods Forty postoperative respiratory failure patients on mechanical ventilation were treated by rhGH 8?IU injection subcutaneously QD.ResultsThe time of mechanical ventilation of rhGH group was (30?12)?d, compared with that in 40 control patients (39?13)?d (t=2 538,P
2.Experience of doctor-patient communication skills training for residents in oncology department
Li WANG ; Shukui QIN ; Ruwen WANG ; Yaoguang JIANG ; Yunping ZHAO
Chinese Journal of Medical Education Research 2012;11(8):858-861
With the increasing of doctor-patient conflicts,the communication between them gradually becomes a critical element in medical service activities.How to improve the doctor-patient communication is an important content in resident communication skill training.Oncology is a developing discipline with fast development and high risk and residents in oncology department need more communications with patients in the era which individualized treatment is emphasized.Systematization and institutionalization of the training system of doctor-patient communication is beneficial to popularizing doctor-patient communication experiences,protecting the rights and interests of them and ensuring the smooth process of medical treatment.
3.Review of Filtering Algorithms for Medical Ultrasonic Images
Shukui ZHAO ; Deyu LI ; Tianfu WANG ; Changqiong ZHENG ; Yi ZHENG
Journal of Biomedical Engineering 2001;18(1):145-148
Several kinds of filters for medical ultrasonic images, suchas multidimensional filter, adaptive weighted filter (for example, adaptive weighted median filter), adaptive window selecting filter (for example , homogeneous region growing mean filter and adaptive speckle suppression filter ) and two-step filter, are introduced. The existing problems and the progress trend are also discussed. Some application instances for medical ultrasonic images of the filters discussed and the performance of the filters presented are based on the present authors' practice.
4.Auto-detection of Contour in Echocardiographic Images Based on Active Contour Model
Aijun HE ; Tianfu WANG ; Changqiong ZHENG ; Deyu LI ; Shukui ZHAO ; Yi ZHENG
Journal of Biomedical Engineering 2001;18(2):242-246,253
Contour detection is one of the most difficult problems in the multi-dimensional reconstruction of echocardiographic images. A method based on active contour model is presented in the present paper to solve this problem. First, according to the characteristic of the ultrasonic medical images, an adaptive weighted median filter is used to suppress speckle noise and an adaptive threshold value is selected to get binary image. Then, mathematical morphological treatment is utilized to get the initial contour. At last, active contour model is employed to revise the initial contour and get the accurate final contour. Experiments with real and interpolated ultrasonic images are presented. The results show the effectiveness of this method. This method has practical use in the multi-dimensional reconstruction of ultrasonic medical images.
5.Cardiac conductive system excitation maps using intracardiac tissue Doppler imaging.
Lixue YIN ; Changqiong ZHENG ; Li CAI ; Yi ZHENG ; Chunmei LI ; Yan DENG ; Yun LUO ; Deyu LI ; Shukui ZHAO
Chinese Medical Journal 2003;116(2):278-283
OBJECTIVETo precisely visualize cardiac anatomic structures and simultaneously depict electro-mechanical events for the purpose of precise underblood intervention.
METHODSIntracardiac high-resolution tissue Doppler imaging was used to map real time myocardial contractions in response to electrical activation within the anatomic structure of the cardiac conductive system using a canine open-chest model.
RESULTSThe detailed inner anatomic structure of the cardiac conductive system at different sites (i.e., sino-atrial, atrial wall, atrial-ventricular node and ventricular wall) with the inside onset and propagation of myocardial velocity and acceleration induced by electrical activation was clearly visualized and quantitatively evaluated.
CONCLUSIONThe simultaneous single modality visualization of the anatomy, function and electrical events of the cardiac conductive system will foster target pacing and precision ablation.
Animals ; Dogs ; Echocardiography, Doppler ; Electrocardiography ; Heart Conduction System ; diagnostic imaging ; physiology ; Myocardial Contraction ; Sinoatrial Node ; diagnostic imaging ; physiology
6.Expression of E-cadherin in the tumor tissue and serum of patients with esophageal squamous cell carcinoma.
Jun ZHANG ; Ying HE ; Shukui WANG ; Wenbin HUANG ; Xingguo CHEN ; Bangshun HE ; Youcai ZHAO ; Jinsong WANG ; Guoxin ZHANG
Journal of Central South University(Medical Sciences) 2012;37(3):228-232
OBJECTIVE:
To survey E-cadherin (E-cad) expression in tumor tissue and serum of esophageal squamous cell carcinoma patients, and to observe the clinical significance of their expression.
METHODS:
Forty-eight samples of esophageal squamous cell carcinoma tissue, 23 samples of erosive esophagitis tissue, 24 samples of normal esophagus tissue and the corresponding sera were obtained. We used immunohistochemistry (IHC) to detect expression of E-cad in the tissues and enzyme-linked immunosorbent assay (ELISA) to examine expression of E-cad in the serum. Furthermore, we collected complete clinicopathological data from the participating patients.
RESULTS:
The expression level of E-cad in the esophageal squamous cell carcinoma tissue was lower than that in normal esophagus tissues and erosive esophagitis tissues (P<0.05). Moreover, the expression level of E-cad was related to the depth of invasion, the status of lymph node metastasis and the level of differentiation of esophageal squamous cell carcinoma (P<0.05). The expression level of serum E-cad of esophageal squamous cell carcinoma patients was obviously higher than that in the serum of normal esophagus controls and erosive esophagitis patients (P<0.05). But the expression level of E-Cad in the serum of esophageal squamous cell carcinoma patients was unrelated to clinicopathological features. The expression level of E-cad in the tissue was not correlated with that in the serum(P=0.134).
CONCLUSION
The expression of E-cad in tissues may assistin the diagnosis and prognosis of esophageal squamous cell carcinoma. The expression of E-cad in the serum may assistin the diagnostic screening of esophageal squamous cell carcinoma.
Aged
;
Aged, 80 and over
;
Antigens, CD
;
Cadherins
;
blood
;
metabolism
;
Carcinoma, Squamous Cell
;
metabolism
;
Enzyme-Linked Immunosorbent Assay
;
Esophageal Neoplasms
;
metabolism
;
Female
;
Humans
;
Immunohistochemistry
;
Male
;
Middle Aged
7.Investigation on the mechanism of EZH2 regulating biological behavior of ovarian cancer cells
Ling ZHU ; Ke WANG ; Feng ZHAO ; Siqi LI ; Shukui WANG ; Qixiang SHAO
Chinese Journal of Clinical Laboratory Science 2024;42(7):542-547
Objective To investigate the mechanism of enhancer of zeste homolog 2(EZH2),a histone methyltransferase,in regula-ting the biological behavior of ovarian cancer(OC)and provide the experimental support for finding new therapeutic targets in the treat-ment of OC.Methods The small interfered RNAs(siRNAs)of EZH2 were used to knock down EZH2 in different OC cell lines,and the interfering efficiency of siEZH2 mRNAs and protein were evaluated by qRT-PCR and Western blot.The cell proliferation,migra-tion,invasion ability and apoptosis of OC cells before and after EZH2 interference were evaluated by the CCK-8,wound healing,Tran-swell and flow cytometry.The expression levels of early growth response 1(EGR1)and H3K27me3 proteins after EZH2 interference were determined by Western blot.Meanwhile,the mechanism of EZH2 regulating the biological behavior of OC cells was explored.Re-sults The expression levels of EZH2 mRNA in OC cells transfected with siEZH2 were significantly lower than that in the negative con-trol group(P<0.05)and the expression levels of EZH2 protein in A2780 cells were also significantly downregulated(P<0.05).The results of Western blot showed that the expression levels of EGR1 and H3K27me3 proteins were reduced to varying degrees.After trans-fection with siEZH2-1,the proliferation ability of A2780 cells in the transfected group was significantly lower than that in the negative control group(P<0.05).The results of the cell scratch test and Transwell test showed that the migration and invasion ability of OC cells transfected with siEZH2-1 were significantly weakened(P<0.05).The results of flow cytometry showed that the apoptosis of OC cells transfected with siEZH2-1 was significantly enhanced(P<0.05).Conclusion EZH2 is highly expressed in OC cells and can promote the proliferation,migration,invasion and anti-apoptosis of A2780 cells.However,EZH2 affects the biological behavior of ovar-ian cancer not by regulating the expression of EGR1 through its H3K27me3 transferase activity.
8.Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2019 version).
Caicun ZHOU ; Jie WANG ; Hong BU ; Baocheng WANG ; Baohui HAN ; You LU ; Zhehai WANG ; Bo ZHU ; Ziping WANG ; Qibin SONG ; Shengxiang REN ; Dongmei LIN ; Yayi HE ; Xiaohua HU ; Hongyun ZHAO ; Shukui QIN
Chinese Journal of Lung Cancer 2020;23(2):65-76
Non-small cell lung cancer (NSCLC) is the most common pathological type of lung cancer, most NSCLC patients are at advanced stage at the time of diagnosis. For patients without sensitive driven-oncogene mutations, chemotherapy is still the main treatment at present, the overall prognosis is poor. Improving outcomes and obtaining long-term survival are the most urgent needs of patients with advanced NSCLC. In recent years, immunotherapy has developed rapidly. Immune checkpoint inhibitors (ICIs), especially targeting programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1), have made a breakthrough in the treatment of NSCLC, beneficial to patients' survival and changed the treatment pattern for NSCLC. It shows more and more important role in the treatment of NSCLC. Led by NSCLC expert committee of Chinese society of clinical oncology (CSCO), relevant experts in this field were organized. On the basis of referring to domestic and foreign literature, systematically evaluating the results of Chinese and foreign clinical trials, and combining the experiences of the experts, the experts group reached an agreement to develop this consensus. It will guide domestic counterparts for better application of ICIs to treat NSCLC.
9.Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2020 Version).
Caicun ZHOU ; Jie WANG ; Baocheng WANG ; Ying CHENG ; Zhehai WANG ; Baohui HAN ; You LU ; Gang WU ; Li ZHANG ; Yong SONG ; Bo ZHU ; Yi HU ; Ziping WANG ; Qibin SONG ; Shengxiang REN ; Yayi HE ; Xiaohua HU ; Jian ZHANG ; Yu YAO ; Hongyun ZHAO ; Zhijie WANG ; Qian CHU ; Jianchun DUAN ; Jingjing LIU ; Shukui QIN
Chinese Journal of Lung Cancer 2021;24(4):217-235
Non-small cell lung cancer (NSCLC) is the most common pathological type of lung cancer. The systemic antitumor therapy of advanced NSCLC has undergone renovations of chemotherapy, targeted therapy and immunotherapy, which results in greatly improved survival for patients with advanced NSCLC. Immune checkpoint inhibitors (ICIs), especially targeting programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1), has changed the treatment paradigm of NSCLC. ICIs have become the standard treatment for advanced NSCLC without epidermal growth factor receptor(EGFR) mutation or anaplastic lymphomakinase(ALK) translocation in the first- or second-line setting, and for locally advanced NSCLC following concurrent radiotherapy and chemotherapy. ICIs are also promising in adjuvant/neoadjuvant therapy. More and more ICIs have been approved domestically for the treatment of NSCLC. Led by the NSCLC expert committee of Chinese Society of Clinical Oncology (CSCO), this consensus was developed and updated based on thoroughly reviewing domestic and foreign literatures, clinical trial data, systematic reviews, experts' discussion and the consensus(2019 version). This consensus will aid domestic clinicians in the treatment of NSCLC with ICIs.
.